Infarto do miocárdio com supradesnivelamento do segmento ST (2016)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- Subjects: INFARTO DO MIOCÁRDIO; DIAGNÓSTICO DIFERENCIAL; BIOMARCADORES; FÁRMACOS (SISTEMA CARDIOVASCULAR)
- Language: Português
- Imprenta:
- ISBN: 9788538807056
- Source:
-
ABNT
BARACIOLI, Luciano Moreira et al. Infarto do miocárdio com supradesnivelamento do segmento ST. Medicina cardiovascular : reduzindo o impacto das doenças. Tradução . São Paulo: Atheneu, 2016. . . Acesso em: 02 nov. 2024. -
APA
Baracioli, L. M., Franken, M., Arantes, F. B. B., & Nicolau, J. C. (2016). Infarto do miocárdio com supradesnivelamento do segmento ST. In Medicina cardiovascular : reduzindo o impacto das doenças. São Paulo: Atheneu. -
NLM
Baracioli LM, Franken M, Arantes FBB, Nicolau JC. Infarto do miocárdio com supradesnivelamento do segmento ST. In: Medicina cardiovascular : reduzindo o impacto das doenças. São Paulo: Atheneu; 2016. [citado 2024 nov. 02 ] -
Vancouver
Baracioli LM, Franken M, Arantes FBB, Nicolau JC. Infarto do miocárdio com supradesnivelamento do segmento ST. In: Medicina cardiovascular : reduzindo o impacto das doenças. São Paulo: Atheneu; 2016. [citado 2024 nov. 02 ] - Ticagrelor versus clopidogrel in patients with STEMI treated with fibrinolysis TREAT trial
- Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial (vol 3, pg 391, 2018)
- Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction Results From the DAPA-HF Trial
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age Insights From DAPA-HF
- Effect of alirocumab on mortality after acute coronary syndromes an analysis of the ODYSSEY OUTCOMES randomized clinical trial
- Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registry
- Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
- Two-year outcomes among stable high-risk patients following acute MI. Insights from a global registry in 25 countries
- Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
- Rationale and design of the long-Term rIsk, clinical manaGement, and healthcare Resource utilization of stable coronary artery dISease in post-myocardial infarction patients (TIGRIS) study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
